M. Oda, Y. Terao, J. Sakurai, M. Nagahama: Membrane-Binding Mechanism of Clostridium perfringens Alpha-Toxin. In: Toxins. Band 7, Nummer 12, Dezember 2015, S. 5268–5275, doi:10.3390/toxins7124880, PMID 26633512, PMC 4690130 (freier Volltext).
J. Sakurai, M. Nagahama, M. Oda: Clostridium perfringens alpha-toxin: characterization and mode of action. In: Journal of biochemistry. Band 136, Nummer 5, November 2004, S. 569–574, doi:10.1093/jb/mvh161, PMID 15632295.
C. E. Naylor, J. T. Eaton, A. Howells, N. Justin, D. S. Moss, R. W. Titball, A. K. Basak: Structure of the key toxin in gas gangrene. In: Nature structural biology. Band 5, Nummer 8, August 1998, S. 738–746, doi:10.1038/1447, PMID 9699639.
nih.gov
ncbi.nlm.nih.gov
M. M. Awad, A. E. Bryant, D. L. Stevens, J. I. Rood: Virulence studies on chromosomal alpha-toxin and theta-toxin mutants constructed by allelic exchange provide genetic evidence for the essential role of alpha-toxin in Clostridium perfringens-mediated gas gangrene. In: Molecular microbiology. Band 15, Nummer 2, Januar 1995, S. 191–202, PMID 7746141.
M. Oda, Y. Terao, J. Sakurai, M. Nagahama: Membrane-Binding Mechanism of Clostridium perfringens Alpha-Toxin. In: Toxins. Band 7, Nummer 12, Dezember 2015, S. 5268–5275, doi:10.3390/toxins7124880, PMID 26633512, PMC 4690130 (freier Volltext).
J. Sakurai, M. Nagahama, M. Oda: Clostridium perfringens alpha-toxin: characterization and mode of action. In: Journal of biochemistry. Band 136, Nummer 5, November 2004, S. 569–574, doi:10.1093/jb/mvh161, PMID 15632295.
C. E. Naylor, J. T. Eaton, A. Howells, N. Justin, D. S. Moss, R. W. Titball, A. K. Basak: Structure of the key toxin in gas gangrene. In: Nature structural biology. Band 5, Nummer 8, August 1998, S. 738–746, doi:10.1038/1447, PMID 9699639.
M. Nagahama: Vaccines against Clostridium perfringens alpha-toxin. In: Current pharmaceutical biotechnology. Band 14, Nummer 10, 2013, S. 913–917, PMID 24372250.